Tirzepatide is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This novel mechanism engages both incretin pathways simultaneously, providing enhanced glycaemic regulation and metabolic effects compared to single-receptor agonists. Clinical research has demonstrated significant effects on HbA1c reduction and body weight. Each vial contains 10 mg at ≥98.5% purity.
Category: Metabolic
Purity: ≥98.5%
Quantity: 10 mg per vial
Format: Lyophilized powder
Add 1-2 mL of bacteriostatic water. Swirl gently — do not shake.
Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2-8°C and use within 30 days.
Ships from Chilliwack, BC via Xpresspost. 2-3 business day delivery. Discreet, insulated packaging.
Your cart is empty.